These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34640606)

  • 21. The Migratory Properties and Numbers of T Regulatory Cell Subsets in Circulation Are Differentially Influenced by Season and Are Associated With Vitamin D Status.
    Lamikanra AA; Tsang HP; Elsiddig S; Spencer M; Curnow E; Danby R; Roberts DJ
    Front Immunol; 2020; 11():685. PubMed ID: 32508805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of immunoregulatory T cells in different stages of breast cancer patients.
    Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
    Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients.
    Elsheshtawy NM; Saad M; El-Ghamrini YM; Ziada KW
    Egypt J Immunol; 2021 Jul; 28(3):145-156. PubMed ID: 34453786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
    Yu Y; Huang R; Zong X; He X; Mo W
    BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implications.
    Liu S; Sun X; Luo J; Zhu H; Yang X; Guo Q; Song Y; Sun X
    Am J Cancer Res; 2015; 5(11):3276-85. PubMed ID: 26807310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes.
    Zhen Y; Sun L; Liu H; Duan K; Zeng C; Zhang L; Jin D; Peng J; Ding W; Zhao Y
    Cell Mol Immunol; 2012 Jan; 9(1):75-85. PubMed ID: 21983870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.
    Tanchot C; Terme M; Pere H; Tran T; Benhamouda N; Strioga M; Banissi C; Galluzzi L; Kroemer G; Tartour E
    Cancer Microenviron; 2013 Aug; 6(2):147-57. PubMed ID: 23104434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
    Chu ZQ; Ji Q
    Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Providence of the CD25
    Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
    Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of regulatory T cells to cancer: A review.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):7983-7993. PubMed ID: 30317612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forkhead-Box-P3 Gene Transfer in Human CD4
    Passerini L; Bacchetta R
    Front Immunol; 2017; 8():1282. PubMed ID: 29075264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human CD4
    Fayyad-Kazan M; Rouas R; Merimi M; Najar M; Badran B; Lewalle P; Fayyad-Kazan H
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(11):919-929. PubMed ID: 37246921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
    Cui G; Li Z; Ren J; Yuan A
    Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased peripheral CD4
    Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
    J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
    Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
    BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T Cells in the Tumor Microenvironment.
    Dadey RE; Workman CJ; Vignali DAA
    Adv Exp Med Biol; 2020; 1273():105-134. PubMed ID: 33119878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.